Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …

Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes

TD Ricketts, N Prieto-Dominguez, PS Gowda… - Frontiers in …, 2021 - frontiersin.org
Macrophages are a specialized class of innate immune cells with multifaceted roles in
modulation of the inflammatory response, homeostasis, and wound healing. While …

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Z Jiang, SO Lim, M Yan, JL Hsu, J Yao… - The Journal of …, 2021 - Am Soc Clin Investig
Immune checkpoint blockade therapy has demonstrated promising clinical outcomes for
multiple cancer types. However, the emergence of resistance as well as inadequate …

TAM family kinases as therapeutic targets at the interface of cancer and immunity

D DeRyckere, JM Huelse, HS Earp… - Nature Reviews Clinical …, 2023 - nature.com
Novel treatment approaches are needed to overcome innate and acquired mechanisms of
resistance to current anticancer therapies in cancer cells and the tumour immune …

Macrophage‐mediated tumor cell phagocytosis: opportunity for nanomedicine intervention

X Zhou, X Liu, L Huang - Advanced functional materials, 2021 - Wiley Online Library
Macrophages are one of the most abundant non‐malignant cells in the tumor
microenvironment, playing critical roles in mediating tumor immunity. As important innate …

Neutrophil heterogeneity in cancer: from biology to therapies

P Lecot, M Sarabi, M Pereira Abrantes… - Frontiers in …, 2019 - frontiersin.org
Neutrophils have been extensively described in the pathophysiology of autoimmune and
infectious diseases. Accumulating evidence also suggests the important role of neutrophils …

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy

OM Soltan, ME Shoman, SA Abdel-Aziz… - European Journal of …, 2021 - Elsevier
Protein kinases have grown over the past few years as a crucial target for different cancer
types. With the multifactorial nature of cancer, and the fast development of drug resistance …

Efferocytosis nanoinhibitors to promote secondary necrosis and potentiate the immunogenicity of conventional cancer therapies for improved therapeutic benefits

Y Wu, C Wang, Y Yan, Y Hao, B Liu, Z Dong, M Chen… - ACS …, 2023 - ACS Publications
Efferocytosis of apoptotic cancer cells by tumor-associated macrophages or other
phagocytes is reported to promote tumor immunosuppression by preventing them from …

Nanomedicine‐based immunotherapy for the treatment of cancer metastasis

P Zhang, Y Zhai, Y Cai, Y Zhao, Y Li - Advanced Materials, 2019 - Wiley Online Library
Metastasis is the leading cause of cancer‐associated death, with poor prognosis even after
extensive treatment. The dormancy of metastatic cancer cells during dissemination or after …

Gas6/Axl signaling pathway in the tumor immune microenvironment

M Tanaka, DW Siemann - Cancers, 2020 - mdpi.com
Receptor tyrosine kinases have been shown to dysregulate a number of pathways
associated with tumor development, progression, and metastasis. Axl is a receptor tyrosine …